Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-14

Clinical Trial Update: Allergic Rhinitis, Immunotherapy and Vitamin d [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on allergic rhinitis exploring immunotherapy with vitamin D in Phase 2 and Phase 3 trials, sponsored by Hospital General de Mexico.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allergen Immunotherapy
  • Vitamin D (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Hospital General de Mexico | Conditions: Allergy | Phase 2, Phase 3 | Status: UNKNOWN